GreenLight Biosciences is a privately-held biotechnology company focused on sustainable production of chemicals and fuels using its Unconstrained Metabolism ® technology platform. This revolutionary technology enables the biological conversion of economical, renewable substrates to valuable products with unprecedented flexibility and control.

Research Grants 1 show all


Patents 117show all

  • 67
    C12N - Microorganisms or enzymes
  • 67
    C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
  • 36
    C12Y - Enzymes
  • 23
    C07K - Peptides
  • 22
    Y02E - Reduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution
  • 13
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 13
    C40B - Combinatorial chemistry
  • 13
    Y02P - Climate change mitigation technologies in the production or processing of goods
  • 2
    C07H - Sugars

SEC Filings show all


Contact Information

200 Boston Avenue Suite 1000
Medford, MA 02155
United States


Total FundingEmployeesLast Funding DateStatus

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2020-05-12$17,000,000Series FXeraya Capital, Flu Lab, Baird Capital
2019-01-08$50,000,000Series EBaird Capital, S2G VenturesTechAccel, Continental Grain Company, Alexandria Venture Investments, Blue I/O, Tao Capital Partners
2015-07-22Series CSyngenta Ventures
2013-12-20$1,000,000Series A
2017-09-13$18,000,000Series DFall Line CapitalRivas Capital, Kodiak Venture Partners, S2G Ventures, Syngenta Ventures, Lewis & Clark Ventures
2015-06-17$20,000,000Series B
2013-08-12$7,000,000Series AKhosla Ventures, Kodiak Venture Partners

SEC Form D Funding Events


Key Executives

  • Andrey Zarur
    Executive Officer, Director
  • James Swartz
  • Jonathan Fleming
  • Charles Cooney
  • Neil Renninger
  • David Furneaux
  • Greg Lucier